Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Major Shareholder Fosun Pharmaceutical Shanghai Sells 1,300 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 1,300 shares of Nature’s Sunshine Products stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $13.12, for a total value of $17,056.00. Following the sale, the insider now directly owns 66,467 shares in the company, valued at $872,047.04. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Fosun Pharmaceutical Shanghai also recently made the following trade(s):

• On Thursday, October 10th, Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00.
• On Tuesday, October 8th, Fosun Pharmaceutical Shanghai sold 1,800 shares of Nature’s Sunshine Products stock. The stock was sold at an average price of $13.13, for a total transaction of $23,634.00.
• On Tuesday, October 1st, Fosun Pharmaceutical Shanghai sold 1,399 shares of Nature’s Sunshine Products stock. The shares were sold at an average price of $13.54, for a total transaction of $18,942.46.

Nature’s Sunshine Products Stock Up 0.2 %

NATR opened at $13.34 on Friday. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $21.72. The company has a fifty day moving average of $13.33 and a 200-day moving average of $15.45. The stock has a market cap of $249.86 million, a PE ratio of 15.69 and a beta of 0.87.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). Nature’s Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%. The business had revenue of $110.55 million for the quarter.

Analyst Upgrades and Downgrades

NATR has been the topic of several analyst reports. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a research note on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective on the stock. Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 target price on the stock. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th. Finally, DA Davidson cut their price objective on Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, August 12th.

Institutional Investors Weigh In On Nature’s Sunshine Products

Large investors have recently added to or reduced their stakes in the business. Wasatch Advisors LP lifted its stake in Nature’s Sunshine Products by 20.6% in the first quarter. Wasatch Advisors LP now owns 518,161 shares of the company’s stock valued at $10,762,000 after buying an additional 88,433 shares during the period. Paradigm Capital Management Inc. NY increased its stake in shares of Nature’s Sunshine Products by 26.8% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock valued at $10,475,000 after acquiring an additional 146,879 shares in the last quarter. Janney Montgomery Scott LLC increased its stake in shares of Nature’s Sunshine Products by 8.9% in the 1st quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock valued at $523,000 after acquiring an additional 2,054 shares in the last quarter. Panagora Asset Management Inc. lifted its position in shares of Nature’s Sunshine Products by 8.3% during the 2nd quarter. Panagora Asset Management Inc. now owns 70,338 shares of the company’s stock valued at $1,060,000 after acquiring an additional 5,392 shares during the period. Finally, Lazard Asset Management LLC boosted its stake in Nature’s Sunshine Products by 16.5% during the first quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock worth $146,000 after acquiring an additional 998 shares in the last quarter. Institutional investors and hedge funds own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.